Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

The requested reference [156c3d625a43d01f09a7f300654fb6fc8c36689c] no longer exists in our database. It has been replaced by the current reference: [78aa7070e86b3911a58cde072b2f3b7f6132c9fd]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
Itopride is a new compound that is already marketed in Japan and in some countries of Eastern Europe under the name of Ganaton. It is used to treat symptoms associated with gastroparesis. Due to inadequate gastric emptying, these patients often have symptoms of bloating, nausea and vomiting following ingestion of a meal. The goal of this study is to evaluate the effects of Itopride on gastric motor function and glycemia in patients with diabetes.
Epistemonikos ID: 46e36f78d0b51e0099029501130e9cff8ac24040
First added on: May 04, 2024